FDA’s 2023 cybersecurity guidance encourages adopting a security-by-design for manufacturing medical devices. Recommend practices include holistic security implementation and deploying technologies for application security testing and supply chain risk analysis. The integration of security checks in continuous integration pipelines and collaboration with stakeholders are also recommended. This update focuses on addressing risks leading to device malfunctions and sensitive data breaches, with potential repercussions like reputational damage and hefty fines.
A Threat-Intelligence Based Approach to Address Uncertainty in Cyber Risk Analysis and Improve Decision-Making – Wiley Online Library
Hey there, fellow Bay Area dwellers! In a world where online threats are part of daily lives, I’m sure you know that cyber risks are
